logo

For the Inventor, By the Inventor

Toorak, Australia

Vegenics Limited


USPTO Granted Patents = 19

% Expired Patents = 78.9



Forward Citations = 132

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Kari Alitalo (15 out of 72 patents)

silverMedal Marc Gregory Achen (9 out of 24 patents)

bronzeMedal Steven Alan Stacker (7 out of 22 patents)

4.  Vladimir Joukov (4 out of 16 patents)

5.  Andrew Frederick Wilks (3 out of 34 patents)

6.  Megan E Baldwin (2 out of 4 patents)

7.  Stephen A Stacker (2 out of 4 patents)

8.  Bradley McColl (2 out of 2 patents)

9.  Markku Michael Jeltsch (2 out of 10 patents)

10.  Ulf Eriksson (1 out of 43 patents)

11.  Taija Makinen (1 out of 4 patents)

12.  Robert Ferrell (1 out of 10 patents)

13.  David Finegold (1 out of 5 patents)

14.  Christoph Renner (1 out of 8 patents)

15.  Marika Karkkainen (1 out of 3 patents)


19 patents:

1. 7947472 - Expression vectors and cell lines expressing vascular endothelial growth factor D (2011-05-24),
2. 7887800 - Methods for inhibiting VEGF-D (2011-02-15),
3. 7871798 - Mammalian cells that express VEGF-D polypeptides (2011-01-18),
4. 7855178 - Growth factor binding constructs materials and methods (2010-12-21),
5. 7846437 - Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same (2010-12-07),
6. 7829536 - Method of treating lymphedema comprising administering VEGF-D (2010-11-09),
7. 7829091 - Therapy targeting FLT4 (VEGER-3) expressed in blood vessels (2010-11-09),
8. 7794756 - Methods of using antibodies to VEGF-C (2010-09-14),
9. 7785803 - Antibody diagnostic kits and methods of use (2010-08-31),
10. 7727761 - Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof (2010-06-01),
11. 7709270 - Vascular endothelial growth factor C (VEGF-C) protein diagnostic (2010-05-04),
12. 7662932 - Vascular endothelial growth factor D (VEGF-D) polypeptides and methods of use (2010-02-16),
13. 7611711 - VEGFR-3 inhibitor materials and methods (2009-11-03),
14. 7534572 - Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue (2009-05-19),
15. 7479270 - Methods and compositions for activating VEGF-D and VEGF-C (2009-01-20),
Company Overview
Vegenics Limited is an innovative company based in Toorak, Australia, specializing in the development of plant-based solutions and technologies. The organization focuses on creating sustainable products that cater to the growing demand for environmentally friendly alternatives in various industries. With a commitment to research and development, Vegenics Limited explores advancements in agricultural biotechnology and food science, aiming to enhance the quality and accessibility of plant-derived offerings while promoting health and sustainability.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

19 Patents

#1 in Toorak

#188 in Australia

#32,693 in the World

Toorak, AU
Toorak, Australia

Vegenics Limited

Forward Citations = 132

19 inventors:

goldMedal Kari Alitalo (15 out of 72 patents)

silverMedal Marc Gregory Achen (9 out of 24 patents)

bronzeMedal Steven Alan Stacker (7 out of 22 patents)

4.  Vladimir Joukov (4 out of 16 patents)

5.  Andrew Frederick Wilks (3 out of 34 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vegenics Limited. Retrieved from https://idiyas.com/company/vegenics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…